For example, dinaciclib, a potent CDK1/2/5/9 inhibitor, has been shown to induce apoptosis of cancer cells, and its combination with checkpoint immunotherapy resulted in an enhanced anti-tumor response [75]. Here, CDK1 is linked to neoplasm.